NanGenex, member of the DRGT Group, is a druggability enabling technology company. The company utilizes its integrated Super-API technology to provide breakthrough solutions to pharmaceutical and biotech companies in order to develop new generations of drugs with significant performance benefits over conventional approaches.

The technology enables NanGenex to generate proprietary drugs by altering their physico-chemical properties to substantially improve their solubility, dissolution rate and bioavailability.